Legislation recently introduced in the Senate has the dietary supplement industry’s attention for reasons other than proposing a solution to the Food and Drug Administration’s hemp conundrum more appealing than a House bill introduced earlier in the year.
Senate Hemp Regulation Bill’s Broad Prohibition On Synthetics In Supplements Has Industry Attention
Provision in Wyden and Merkley’s “Cannabinoid Safety and Regulation Act” referencing FDA authority outside hemp-derived ingredients could provide agency with needed authority to force from the market products labeled as supplements but containing drugs or eliminate the use of many safe ingredients in supplements.